Quest Partners LLC Sells 1,563 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Quest Partners LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 70.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 654 shares of the company’s stock after selling 1,563 shares during the quarter. Quest Partners LLC’s holdings in HCA Healthcare were worth $210,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of HCA. Avantax Advisory Services Inc. increased its stake in HCA Healthcare by 8.5% in the fourth quarter. Avantax Advisory Services Inc. now owns 4,669 shares of the company’s stock worth $1,264,000 after purchasing an additional 364 shares during the period. Level Four Advisory Services LLC increased its stake in HCA Healthcare by 11.2% in the fourth quarter. Level Four Advisory Services LLC now owns 2,458 shares of the company’s stock worth $665,000 after purchasing an additional 248 shares during the period. Independent Advisor Alliance increased its stake in HCA Healthcare by 8.2% in the fourth quarter. Independent Advisor Alliance now owns 948 shares of the company’s stock worth $257,000 after purchasing an additional 72 shares during the period. Norges Bank purchased a new position in shares of HCA Healthcare during the fourth quarter valued at $694,985,000. Finally, Gladstone Institutional Advisory LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at $200,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 in the last quarter. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Up 0.8 %

HCA Healthcare stock opened at $394.68 on Monday. The business has a 50 day simple moving average of $362.19 and a 200-day simple moving average of $338.12. The stock has a market capitalization of $101.86 billion, a PE ratio of 19.67, a price-to-earnings-growth ratio of 1.46 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $403.05.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.29 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 22.46 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Analysts Set New Price Targets

HCA has been the topic of several research reports. Barclays raised their price target on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research note on Wednesday, July 24th. Truist Financial raised their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 1st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a research note on Monday, August 19th. Finally, Wells Fargo & Company lifted their target price on HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research note on Tuesday, July 30th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and three have issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.